86 related articles for article (PubMed ID: 17603393)
21. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
[TBL] [Abstract][Full Text] [Related]
22. A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause.
Lewis JE; Nickell LA; Thompson LU; Szalai JP; Kiss A; Hilditch JR
Menopause; 2006; 13(4):631-42. PubMed ID: 16837885
[TBL] [Abstract][Full Text] [Related]
23. [Transvaginal sonography of the postmenopausal endometrium].
Curcić A; Segedi D; Belopavlović Z; Petrović D
Med Pregl; 2000; 53(1-2):59-63. PubMed ID: 10953553
[TBL] [Abstract][Full Text] [Related]
24. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Femarelle for the treatment of climacteric syndrome in postmenopausal women: An open label trial.
Chen FP; Chang CJ; Chao AS; Huang HY; Huang JP; Wu MH; Tsai CC; Kung FT; Chang CW; Tsai YC
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):336-40. PubMed ID: 27343311
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy of standardized isoflavones extract (Soyfem) (52-104 mg/24h) in moderate and medium-severe climacteric syndrome].
Drews K; Seremak-Mrozikiewicz A; Puk E; Kaluba-Skotarczak A; Malec M; Kazikowska A
Ginekol Pol; 2007 Apr; 78(4):307-11. PubMed ID: 17621994
[TBL] [Abstract][Full Text] [Related]
28. Effects of tibolone on the endometrium.
Völker W; Coelingh Bennink HJ; Helmond FA
Climacteric; 2001 Sep; 4(3):203-8. PubMed ID: 11588943
[TBL] [Abstract][Full Text] [Related]
29. Screening transvaginal uterine ultrasonography for identifying endometrial pathology in postmenopausal women.
Paraskevaidis E; Papadimitriou D; Kalantaridou SN; Pappa L; Malamou-Mitsi V; Zikopoulos K; Kazantzis E; Lolis ED; Agnantis NJ
Anticancer Res; 2002; 22(2B):1127-30. PubMed ID: 12168911
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms].
Bai WP; Wang SY; Liu JL; Geng L; Hu LN; Zhang ZL; Chen SL; Zheng SR
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):597-600. PubMed ID: 20003788
[TBL] [Abstract][Full Text] [Related]
31. An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms.
Fleischer AC; Wheeler JE; Lindsay I; Hendrix SL; Grabill S; Kravitz B; MacDonald B
Am J Obstet Gynecol; 2001 Jan; 184(2):70-5. PubMed ID: 11174482
[TBL] [Abstract][Full Text] [Related]
32. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
Liu ZM; Ho SC; Woo J; Chen YM; Wong C
Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
[TBL] [Abstract][Full Text] [Related]
33. Abnormal sonographic endometrial findings in asymptomatic postmenopausal women: possible role of antihypertensive drugs.
Pardo J; Aschkenazi S; Kaplan B; Orvieto R; Nitke S; Ben-Refael Z
Menopause; 1998; 5(4):223-5. PubMed ID: 9872488
[TBL] [Abstract][Full Text] [Related]
34. Endometrial, breast and liver safety of soy isoflavones plus Lactobacillus sporogenes in post-menopausal women.
Colacurci N; De Franciscis P; Atlante M; Mancino P; Monti M; Volpini G; Benvenuti C
Gynecol Endocrinol; 2013 Mar; 29(3):209-12. PubMed ID: 23194023
[TBL] [Abstract][Full Text] [Related]
35. Intrauterine levonorgestrel delivered by a frameless system, combined with systemic estrogen: acceptability and endometrial safety after 3 years of use in peri- and postmenopausal women.
Wildemeersch D; Janssens D; Schacht E; Pylyser K; de Wever N
Gynecol Endocrinol; 2005 Jun; 20(6):336-42. PubMed ID: 16019384
[TBL] [Abstract][Full Text] [Related]
36. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
37. Transvaginal ultrasonography and endometrial cytology as a diagnostic schema for endometrial cancer.
Minagawa Y; Sato S; Ito M; Onohara Y; Nakamoto S; Kigawa J
Gynecol Obstet Invest; 2005; 59(3):149-54. PubMed ID: 15637434
[TBL] [Abstract][Full Text] [Related]
38. Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women.
Ronkin S; Northington R; Baracat E; Nunes MG; Archer DF; Constantine G; Pickar JH
Obstet Gynecol; 2005 Jun; 105(6):1397-404. PubMed ID: 15932835
[TBL] [Abstract][Full Text] [Related]
39. Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries.
Penotti M; Fabio E; Modena AB; Rinaldi M; Omodei U; Viganó P
Fertil Steril; 2003 May; 79(5):1112-7. PubMed ID: 12738504
[TBL] [Abstract][Full Text] [Related]
40. Isoflavone treatment for acute menopausal symptoms.
Cheng G; Wilczek B; Warner M; Gustafsson JA; Landgren BM
Menopause; 2007; 14(3 Pt 1):468-73. PubMed ID: 17290160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
